Waud Capital Partners’ healthcare investments extend beyond Acadia Healthcare, though the behavioral health company remains its most prominent creation. The Chicago-based private equity firm, founded by Reeve Waud in 1993, has built and exited numerous healthcare platforms, applying a consistent investment philosophy across different healthcare services sectors.
The January 2026 appointment of Debbie Osteen as Acadia’s CEO reflects Waud’s continued involvement with the company he founded in 2005.
A Diverse Healthcare Portfolio
Waud Capital specializes in two sectors: healthcare and software/technology. Within healthcare, the firm has invested across physician practice management, specialty healthcare services, pharmaceutical services, and behavioral health.
The firm typically takes controlling positions in portfolio companies and executes growth strategies combining organic expansion with add-on acquisitions. Healthcare platforms under Waud Capital ownership average more than 10 add-on acquisitions during the holding period.
GI Alliance: A $2.2 Billion Exit
GI Alliance demonstrates Waud Capital’s healthcare investment approach. The firm partnered with physician executives in 2018 to create a platform consolidating gastroenterology practices. Over four years, GI Alliance grew from operations in 2 states to 14 states, becoming the largest independent GI practice management company in the nation.
Waud Capital exited its controlling stake in 2022 through a physician-led buyout and recapitalization valued at approximately $2.2 billion. Apollo Global Management joined as a new investment partner, allowing Waud Capital to realize its investment while the company continued growing under new ownership.
Current Investments
Waud Capital’s current healthcare portfolio includes companies across several subsectors. Ivy Rehab operates outpatient physical therapy clinics. Unifeye Vision Partners provides eye care practice management services. PromptCare offers home infusion and specialty pharmacy services. APDerm operates dermatology practices.
Each platform follows the Waud Capital model: partner with experienced management, provide growth capital, execute add-on acquisitions, and build scale within a focused healthcare niche.
The Acadia Model Applied Elsewhere
Reeve Waud founded Acadia Healthcare in 2005 and guided it to a 2011 IPO. While Waud Capital’s direct ownership ended with the public offering, the Acadia approach-identifying a fragmented healthcare sector, building a platform, and scaling through acquisitions and organic growth-characterizes the firm’s healthcare investments broadly.
Waud’s continued role as Acadia Board Chairman demonstrates sustained engagement beyond initial investment. His January 2026 announcement appointing Osteen as CEO reflects hands-on governance extending decades past the company’s founding.
Read: Acadia Healthcare Appoints Debbie Osteen as Chief Executive Officer
